Nwosu [20] studied the effect of adjunctive ergocalciferol on residual β-cell function and partial clinical remission in youth with newly diagnosed type 1 diabetes maintained on a standardized insulin treatment for a 12-month period. The gene discussed is INS; the disease is type 1 diabetes mellitus.